Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

17:12) is one of sev- eral that have been interpreted by some religious groups to extend to acceptance of blood products in a medical context. Jehovah’s Witnesses, for example, may refuse potentially vital blood transfusions on such grounds. These views must be respected, but complex issues arise if the patient is a child, or an adult who may not be able to give or withhold consent in an informed way. In an immediately life-threatening situation where further delay may cause harm, treatment such as blood products may be given in the child’s best interest, but the team should always involve senior paediatricians and hospital ethicists where practical. If the requirement is less immediate, then the clinicians should seek further legal advice, which might involve approaching the Courts. __OOHHCCMM__1100ee..iinnddbb 334499 0022//0055//22001177 1199::0077 ygolotameaH 350 Anticoagulants Main indications • Therapeutic: Venous thromboembolic disease: DVT and PE. • Prophylactic: Prevention of DVT/PE in high-risk patients (p375), eg post-op. Prevention of stroke, eg in chronic AF or prosthetic heart valves. Heparin 1 Low-molecular-weight heparin (LMWH): Eg dalteparin, enoxaparin, tinzapa- rin. The preferred option in the prevention and initial treatment of venous thromboem- bolism. Inactivates factor Xa (but not thrombin). t½ is 2- to 4-fold
